Cosmetics

Consumer Health And Wellness Market Outlook: What Trends Will Impact Self-Care In 2026?

In contributed commentary, Susan Levy, SBL Consulting Group founder and principal, discusses likely health and wellness market developments which would reflect a steady shift toward more accessible, consumer-centric models of care complementing traditional healthcare.

US FDA Review Team Split On Amgen’s Tavneos Years Before Withdrawal Request

The clinical and statistical review teams favored a complete response letter for the vasculitis treatment, while the review division and office directors supported approval.

Kenvue Shareholder Meeting Shows Strong Support To Accept Kimberly-Clark’s Nearly $50Bn Offer

Both companies announced that during special meetings on Jan. 29, their shareholders voted nearly unanimous support for Kimberly-Clark’s $48.7bn acquisition proposed in November at $3.50 per share plus 0.14625 share for each Kenvue share.

With Marketplace ‘Changing Faster Than Ever,’ P&G Sticks With Established Growth Strategies

“We remain fully committed to the integrated growth strategy that has enabled us to deliver significant growth and value creation, over the better part of the past decade,” says CEO Shailesh Jejurikar as firm reports net sales up 1% in latest quarter.

US Consumer Health In 2026: Understanding Regulatory Changes, Consumer Preferences

Consumer health product industry regulatory experts discuss two central questions: What trends, challenges, or opportunities do you expect will define the industry in 2026? Did developments you anticipated materialize?

US Consumer Health In 2026: Using Regulatory Opportunities, Protecting Consumer Access

Industry trade group executives discuss two central questions: What trends, challenges, or opportunities do you expect will define the industry in 2026? Did developments you anticipated materialize?

Q&A: Proposed US Sunscreen Monograph Addition Shines Light On Questions As Well As Opportunities

“Our sense is that companies are currently focused on timing, scope and execution. For example, knowing when a final order might issue … We also imagine that formulators are scrutinizing the proposed list of permitted combinations, the 6% cap, and the permitted dosage forms,” say ArentFox Schiff att

Makary Touts ‘AI Revolution,’ Announces Guidance Docs On Wellness Products, Decision Support Tool

FDA Commissioner Marty Makary announced new guidance documents on wellness products and decision support tools focused on AI technology at CES in Las Vegas. The documents aim to reduce regulatory hurdles and promote innovation while ensuring public safety.

As US FDA Turns: Can Makary, Prasad And Pazdur Make It Work?

FDA leadership drama continues after Richard Pazdur was elevated to drug center director. Can Pazdur, CBER Director Vinay Prasad and Commissioner Martin Makary get along?

Niagen Bioscience Shines Focus On Consumer Health In Long-COVID Study, Skin Care Launch

Daily Niagen use increased NAD+ levels for subjects in long-COVID study, showing “encouraging within-group improvements” in fatigue, sleep and mood. Tru Niagen Beauty is “cellular-first formula designed to support skin elasticity and the appearance of hair, skin, and nails.”

Senate’s Proposed Agreement To End US Shutdown Would Cut FDA Non-User Fee Funding

But the Senate’s reduction would not be as much as the House of Representatives and President Trump proposed earlier this year, which is likely a win for the agency.

California Firm Too Busy To Defend Ad Claims For NAD+ Supplement It Previously Marketed

Virgin Scent didn’t respond to NAD attorneys’ “repeated outreach attempts” asking for evidence supporting ad claims for Artnaturals NAD+ challenged by another NAD+ supplement marketer, Reus Research.